DOI:10.2214/AJR.07.2779
AJR 2008; 190:1291-1299
© American Roentgen Ray Society
Vascular Malformation and Hemangiomatosis Syndromes: Spectrum of Imaging Manifestations
Khaled M. Elsayes1,
Christine O. Menias2,
Jonathan R. Dillman1,
Joel F. Platt1,
Jonathon M. Willatt1 and
Jay P. Heiken2
1 Department of Radiology, University of Michigan Health System, 1500 E Medical
Center Dr., Ann Arbor, MI, 48109.
2 Mallinckrodt Institute of Radiology, Washington University, St. Louis,
MO.
Received January 27, 2007;
accepted after revision October 7, 2007.
Address correspondence to K. M. Elsayes
(kelsayes{at}med.umich.edu).
Abstract
OBJECTIVE. The purpose of this review is to describe the role of
imaging and associated findings in the diagnosis of blue rubber bleb nevus
syndrome, Proteus syndrome, Klippel-Trénaunay syndrome, and
Kasabach-Merritt syndrome.
CONCLUSION. Blue rubber bleb nevus, Proteus,
Klippel-Trénaunay, and Kasabach-Merritt syndromes are a diverse group
of vascular malformation and hemangiomatosis syndromes. Both cutaneous and
visceral vascular lesions are associated with these disorders. Accurate
diagnosis of these syndromes is important because they can be associated with
serious complications, including life-threatening hemorrhage.
Keywords: hemangioma hemangiomatosis imaging vascular malformation
Introduction
Vascular malformation and hemangiomatosis syndromes, although rare, are a
diverse group of disease entities that have characteristic imaging findings.
The syndromes discussed—blue rubber bleb nevus syndrome, Proteus
syndrome, Klippel-Trénaunay syndrome, and Kasabach-Merritt
syndrome—are characterized by distinctive cutaneous and visceral
vascular lesions. Vascular lesions of the skin have traditionally been
recognized as a clue to the possible existence of these syndromes and
potential for associated visceral vascular malformations and hemangiomas. The
presence of a vascular malformation or hemangiomatosis syndrome often can be
confirmed with a combination of clinical expertise and radiologic evaluation.
The diagnosis of these conditions is important because they can be associated
with numerous complications, including significant bleeding diatheses. We
review the radiologic evaluation of various vascular malformation and
hemangiomatosis syndromes, including the roles of specific imaging techniques
and pertinent imaging findings.
Hemangiomas, Vascular Malformations, and Arteriovenous Malformations
Hemangiomas are benign neoplasms characterized by abnormal proliferation of
blood vessels. These lesions arise from mesenchymal tissue. Histologically,
hemangiomas are composed of multiple vascular channels lined with a single
layer of endothelium and are supported by a fibrous connective tissue
scaffold. Such lesions frequently proliferate early in life before regressing
in size [1].
Vascular malformations are somewhat similar to hemangiomas in that they are
composed of abnormal vascular channels lined with a single layer of dysplastic
endothelium. These lesions, however, do not regress the way hemangiomas do.
Vascular malformations are present at birth because they are congenital,
although they may not become clinically evident until later in life. These
malformations are named after the vascular element they most closely resemble:
capillary, venous, and lymphatic malformations
[1].
Hemangiomas and vascular malformations are not infrequent in the general
population, and they are most commonly limited in extent. These lesions can,
however, become quite large (for example, involving an entire extremity) and
numerous (for example, affecting multiple organ systems). The term
hemangiomatosis may be applied in the setting of very large or numerous
hemangiomas. Large cutaneous hemangiomas and vascular malformations can have
both superficial and deep components
[1]. Hemangiomas and vascular
malformations can involve numerous solid organs, including the liver, spleen,
gastrointestinal tract, brain, and lungs.
Arteriovenous malformations occur when there is an abnormal communication
between the high-pressure arterial system and the low-pressure venous system
without an intervening capillary bed. The site at which abnormally dilated
feeding arteries and veins communicate is called the nidus. Such lesions
typically are associated with increased blood flow (hence, they are called
high-flow lesions) and may result in steal phenomenon
[1].
Blue Rubber Bleb Nevus Syndrome
Blue rubber bleb nevus syndrome (BRBNS) is a rare disorder characterized by
multiple distinctive cutaneous and gastrointestinal venous malformations.
Gascoyen [2] described the
syndrome in 1860. The name of the syndrome is derived from the bluish color of
the associated cutaneous lesions and their rubbery consistency at palpation
[3]. BRBNS usually is sporadic
and generally presents at birth or in early childhood
[4]. The typical cutaneous
venous malformations associated with this condition may or may not increase in
size and number with age. Cutaneous lesions may number from a few to more than
100. These lesions preferentially involve the trunk and upper extremities, can
be painful, and can range from a few millimeters to several centimeters in
diameter.
Vascular malformations of the gastrointestinal tract associated with BRBNS
can manifest as hematemesis, melena, or hematochezia
[5–7].
Early diagnosis and management of this entity is particularly important
because of the risk of life-threatening gastrointestinal hemorrhage
[5]. Consumptive coagulopathy
and iron deficiency anemia secondary to occult bleeding episodes also are
complications [5,
8]. BRBNS has been associated
with the development of certain tumors, including medulloblastoma, chronic
lymphocytic leukemia, renal cell carcinoma, and squamous cell carcinoma
[4]. Because BRBNS is quite
rare, the exact risk of development of each of these neoplasms is unknown.
The most common site of bowel involvement in BRBNS is the small intestine,
although lesions can occur anywhere along the gastrointestinal tract from the
oral cavity to the anus [4].
Multiple diagnostic techniques may be needed to visualize these
gastrointestinal lesions. Such lesions can be evaluated with endoscopy, barium
studies, 99mTc-labeled RBC nuclear scintigraphy, and
contrast-enhanced CT. Fluoroscopic barium examinations may reveal multiple
polypoid filling defects that represent venous malformations, possibly
mimicking a polyposis syndrome. Although endoscopy is more sensitive for small
lesions involving the stomach, duodenum, and colon, barium studies, such as
small-bowel follow-through and enteroclysis examinations, are typically needed
to evaluate the small bowel. The vascular nature of these lesions cannot be
differentiated from other types of polyps solely on the basis of the findings
at barium studies. Vascular malformations of the rectosigmoid colon are
uncommon and can occur in association with BRBNS (Fig.
1A,
1B,
1C).

View larger version (129K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A —32-year-old woman with blue rubber bleb nevus syndrome. Axial
STIR MR image (TR/TE, 5,500/80; inversion time, 165 milliseconds; slice
thickness, 4 mm) shows circumferential rectal wall and perirectal
heterogeneous predominantly high signal intensity.
|
|

View larger version (117K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B —32-year-old woman with blue rubber bleb nevus syndrome. Axial
unenhanced (B) and contrast-enhanced (C) T1-weighted
gradient-recalled echo (225/3.4; flip angle, 70°; slice thickness, 4 mm)
delayed venous phase MR images show abnormal circumferential rectal wall and
perirectal soft-tissue enhancement pathologically proved to represent large
venous malformation.
|
|

View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C —32-year-old woman with blue rubber bleb nevus syndrome. Axial
unenhanced (B) and contrast-enhanced (C) T1-weighted
gradient-recalled echo (225/3.4; flip angle, 70°; slice thickness, 4 mm)
delayed venous phase MR images show abnormal circumferential rectal wall and
perirectal soft-tissue enhancement pathologically proved to represent large
venous malformation.
|
|
Technetium-99m-labeled RBC nuclear scintigraphy can be used to localize the
site of active bleeding in patients with gastrointestinal hemorrhage. This
technique can be particularly important when the findings at endoscopic
evaluation are normal. Vascular lesions arising from sites other than the
gastrointestinal tract (e.g., viscera, musculoskeletal system) also can be
depicted with this imaging technique.
Although it frequently may not show tiny vascular lesions in the small and
large bowel, contrast-enhanced CT can be helpful in evaluating certain
complications related to this syndrome. Complications related to BRBNS that
may be detectable with CT include intestinal intussusception, volvulus,
infarction, and, in rare instances, active gastrointestinal bleeding
[4,
9]. In addition, CT may reveal
phleboliths within bowel-related lesions, suggesting a vascular cause, and may
depict vascular lesions within other solid organs.
MRI is particularly useful for visualizing vascular lesions of the
musculoskeletal system that may be associated with BRBNS. Such lesions can
typically be successfully characterized with MRI. The cutaneous venous
malformations that occur in this syndrome vary in depth and may or may not
involve underlying muscle, bone, and joint spaces (Fig.
2A,
2B). Venous malformations
involving the extremities can be complicated by osseous bowing deformities,
pathologic fractures, and overgrowth. MRI is also valuable in the examination
of vascular lesions within solid organs, such as the liver and spleen. Solid
organ venous malformations associated with this syndrome are typically
well-defined, hypointense to isointense in relation to normal adjacent
parenchyma on T1-weighted images, and hyperintense in relation to normal
adjacent parenchyma on T2-weighted images. These lesions typically become
homogeneously enhanced after IV administration of contrast material. They can
also, however, exhibit peripheral enhancement with subsequent delayed
centripetal fill-in not unlike that of hemangiomas
(Fig. 3). The venous
malformations associated with BRBNS are low-flow lesions and therefore lack
the flow voids that may be seen in high-flow arteriovenous malformations
[1,
4].

View larger version (63K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A —12-year-old girl with blue rubber bleb nevus syndrome.
Coronal STIR (TR/TE, 4,000/26; inversion time, 165 milliseconds; slice
thickness, 5 mm) (A) and contrast-enhanced fat-saturated T1-weighted
spoiled gradient-recalled echo (255/3.3; flip angle, 90°; slice thickness,
5 mm) (B) delayed venous phase MR images show large venous malformation
involving subcutaneous tissue and underlying musculature of left lower
extremity.
|
|

View larger version (61K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B —12-year-old girl with blue rubber bleb nevus syndrome.
Coronal STIR (TR/TE, 4,000/26; inversion time, 165 milliseconds; slice
thickness, 5 mm) (A) and contrast-enhanced fat-saturated T1-weighted
spoiled gradient-recalled echo (255/3.3; flip angle, 90°; slice thickness,
5 mm) (B) delayed venous phase MR images show large venous malformation
involving subcutaneous tissue and underlying musculature of left lower
extremity.
|
|

View larger version (128K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3 —39-year-old man with blue rubber bleb nevus syndrome. Axial
contrast-enhanced portal venous phase fat-saturated T1-weighted spoiled
gradient-recalled echo MR image (TR/TE, 4.2/2.0; flip angle, 12°; slice
thickness, 4 mm) shows multiple peripherally enhanced hemangioma-like lesions
within liver (long arrows), spleen (short arrows), and spine
(arrowheads).
|
|
Proteus Syndrome
Proteus syndrome is a rare congenital condition described by Cohen and
Hayden [10] in 1979. Wiedemann
et al. [11] named this
condition in 1983 after Proteus, the Greek god of the sea, who was able to
change the shape of his body to avoid capture. The name Proteus syndrome thus
refers to the condition's protean nature, particularly the unpredictable
asymmetric partial gigantism and hemihypertrophy typically associated with
this syndrome. Although the cause of Proteus syndrome is not definitely known,
there is evidence to suggest that it occurs after mutation of a somatic
dominant gene that is typically lethal, except in the setting of mosaicism
[12]. Patients with Proteus
syndrome may appear healthy at birth, and consequently the condition may not
be diagnosed until early adulthood. Proteus syndrome is responsible for a
variety of malformations and overgrowths involving multiple tissue types.
Asymmetric overgrowth can involve the skin and skeleton and numerous other
soft-tissue elements (e.g., vascular, fat, muscle, viscera)
[13]. This overgrowth may
manifest itself as hemihypertrophy and partial gigantism, and it typically
results in disfiguring deformities of the skull, hands, and feet.
Soft-tissue abnormalities associated with Proteus syndrome include vascular
malformations (Figs. 4A and
5B), lipomas and fatty
hypertrophy (Figs. 4B and
5A), regional fatty atrophy,
hyperpigmentation, and nevi. Abdominal solid organs may be abnormally enlarged
and exhibit splenomegaly and nephromegaly. Skeletal abnormalities, such as
macrodactyly, exostosis, progressive scoliosis, and limb-length discrepancy,
are frequent and striking findings
[14]. The highly variable
manifestations of Proteus syndrome frequently lead to initial misdiagnosis.
Severe neurofibromatosis type 1, Klippel-Trénaunay syndrome,
hemihyperplasia–multiple lipomatosis syndrome, Maffucci syndrome, and
Ollier disease can be confused with Proteus syndrome. To help minimize such
errors, specific diagnostic criteria have been developed for Proteus syndrome
(Appendix 1) [14,
15]. Consistent application of
these diagnostic criteria allows reliable clinical diagnosis.

View larger version (125K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A —23-year-old man with Proteus syndrome. Axial
contrast-enhanced portal venous phase CT scan through upper abdomen reveals
multiple low-attenuation splenic lesions thought to represent vascular
malformation.
|
|

View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B —10-year-old boy with Proteus syndrome. Axial
contrast-enhanced T1-weighted FLAIR venous phase image (2,055/21; slice
thickness, 4 mm) through level of midthoracic spine reveals enhanced large
right paraspinous presumed vascular malformation (arrows).
|
|

View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B —23-year-old man with Proteus syndrome. Axial CT scan through
lower abdomen shows marked soft-tissue asymmetry, including asymmetric
prominence of right gluteus and iliopsoas muscles (long arrows)
(compared with opposite side) and increased fatty tissue within left lower
quadrant of abdomen and left lateral body wall (short arrows).
|
|

View larger version (129K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A —10-year-old boy with Proteus syndrome. Axial T1-weighted
FLAIR MR image (TR/TE, 2,036/21; slice thickness, 5 mm) through lower abdomen
shows large well-circumscribed mass of high signal intensity in left anterior
abdominal wall consistent with lipoma (arrows).
|
|
A variety of radiologic examinations are useful in the evaluation of
Proteus syndrome. A radiographic skeletal survey can help characterize osseous
manifestations. CT and MRI of the abdomen and pelvis can be used to evaluate
for visceromegaly, visceral vascular malformations (venous, capillary, and
lymphatic), and the presence of asymptomatic but potentially aggressive
intraabdominal and intrapelvic lipomatosis
[16,
17]. MRI of the CNS is
superior to CT in the evaluation of patients with neurologic symptoms. Imaging
findings can include megalencephaly and neuronal migrational abnormalities
(Fig. 6A,
6B)
[18]. CT of the chest is
helpful in evaluation for diffuse cystic emphysematous disease and pulmonary
embolism, both of which occur at an increased frequency in Proteus syndrome
[14,
19].

View larger version (150K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6A —5-year-old boy with Proteus syndrome and megalencephaly.
(Courtesy of Parmar H, University of Michigan Health System, Ann Arbor, MI)
Axial T2-weighted fast spin-echo MR image (TR/TE, 3,200/102; slice thickness,
6 mm) through level of upper cervical spine and maxilla shows extensive right
facial soft-tissue hypertrophy (asterisks).
|
|

View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6B —5-year-old boy with Proteus syndrome and megalencephaly.
(Courtesy of Parmar H, University of Michigan Health System, Ann Arbor, MI)
Axial T2-weighted fast spin-echo MR image (3,200/102; slice thickness, 6 mm)
through level of cerebral hemispheres reveals enlargement of right cerebrum
with associated abnormal cortical sulcation and gyration
(arrowheads).
|
|
Klippel-Trénaunay Syndrome and Parkes Weber Syndrome
Klippel-Trénaunay syndrome is a congenital disorder classically
characterized by three findings: a port-wine stain (nevus flammeus), abnormal
venous structures (such as varicosities and venous malformations), and osseous
and soft-tissue hypertrophy. This syndrome was initially described in 1900 by
Klippel and Trénaunay
[20] and was originally called
naevus vasculosus osteohypertrophicus. In 1907, Frederick Parkes Weber
[21] noted similar findings in
association with arteriovenous malformations. This entity is referred to as
Parkes Weber or Klippel-Trénaunay-Weber syndrome.
The diagnosis of Klippel-Trénaunay syndrome can be made when any two
of the three features are present
[22,
23]. Sixty-three percent of
patients with Klippel-Trénaunay syndrome have all three components of
the triad, and 37% have only two. The lower extremity is the site of
involvement in approximately 95% of patients. The port-wine stain, a cutaneous
capillary vascular malformation, is present in 98% of patients with this
syndrome and is the most common manifestation
[22]. This capillary vascular
malformation typically does not markedly progress or regress with time (unlike
a hemangioma), and it can have both superficial (cutaneous) and deep (muscular
and osseous) components. Osseous and soft-tissue limb hypertrophy is the least
common finding of the three classic features of Klippel-Trénaunay
syndrome [22]. This
hypertrophy can affect both extremity length and circumference, and it can be
the result of local hyperemia and venous stasis secondary to associated venous
abnormalities (Fig. 7). Causes
of venous stasis in Klippel-Trénaunay syndrome include valvular
insufficiency, venous varicosities, venous malformations, obstructed venous
outflow, and abnormal lymphatic drainage. Varicose veins are present in most
patients with Klippel-Trénaunay syndrome and can be superficial, deep,
or perforating [24,
25].

View larger version (99K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7 —19-year-old woman with Klippel-Trénaunay syndrome.
Axial contrast-enhanced CT scan through midthigh level reveals soft-tissue
hypertrophy (arrows) of right thigh, including asymmetrically
increased circumference compared with opposite side.
|
|
Involvement of the gastrointestinal tract may be more common in
Klippel-Trénaunay syndrome than previously believed, occurring in
perhaps as many as 20% of patients, and it may go unrecognized in patients
without overt symptoms
[26–29].
Bleeding is the most common symptom reported in Klippel-Trénaunay
syndrome patients with gastrointestinal involvement. The most frequently
reported sites of gastrointestinal involvement in these patients are the
distal colon and rectum. Genitourinary involvement in patients with
Klippel-Trénaunay syndrome has been described
[26,
27,
30]. Intraabdominal and
intrapelvic extension and external genital involvement of the vascular
malformations may be associated with Klippel-Trénaunay syndrome. In
addition, cavern ous hemangiomas can occur within abdominal solid organs and
the mediastinum and retroperitoneum (Figs.
8 and
9A,
9B)
[31]. Complications associated
with Klippel-Trénaunay syndrome are most often related to the vascular
system. Such complications include stasis dermatitis, thrombophlebitis, and
cellulitis. More serious complications include deep venous thrombosis,
pulmonary embolism, coagulopathy, and congestive heart failure (in patients
with associated arteriovenous malformations).

View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8 —22-year-old man with Klippel-Trénaunay syndrome. Axial
contrast-enhanced portal venous phase CT scan through upper abdomen shows
multiple low-attenuation splenic lesions (arrows), presumably
hemangiomas or vascular malformations.
|
|

View larger version (117K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9A —12-year-old girl with Klippel-Trénaunay syndrome.
Axial (A) and coronal (B) contrast-enhanced CT scans of thorax
show large avidly enhanced mass (arrows) within posterior
mediastinum, including bilateral paraspinous regions, representing
pathologically proven hemangioma.
|
|

View larger version (169K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9B —12-year-old girl with Klippel-Trénaunay syndrome.
Axial (A) and coronal (B) contrast-enhanced CT scans of thorax
show large avidly enhanced mass (arrows) within posterior
mediastinum, including bilateral paraspinous regions, representing
pathologically proven hemangioma.
|
|

View larger version (26K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10A —29-year-old woman with Klippel-Trénaunay syndrome.
Coronal STIR MR image (TR/TE, 4,308/30; inversion time, 165 milliseconds;
slice thickness, 5 mm) of left forearm shows extensive venous malformation
with both superficial and deep venous components.
|
|
Various imaging techniques can be used in the diagnosis of suspected
Klippel-Trénaunay syndrome. Both plain radiography and CT can depict
phleboliths that suggest the presence of a venous malformation. Sonography
with Doppler capabilities can be used to assess the condition of the venous
system within an affected extremity. This imaging technique can be used to
evaluate the anatomic features of both superficial and deep venous structures
and to evaluate for disease-related complications, such as deep venous
thrombosis. MRI can be used to evaluate extremity hypertrophy and vascular
malformations in these patients (Fig.
10A). MR arteriography and MR venography can be used to define
both the type and extent of vascular malformations in Klippel-Trénaunay
syndrome [1]. Specifically, MRI
allows differentiation of low-flow (venous) from high-flow (arteriovenous)
malformations. The venous malformations typi cally associated with
Klippel-Trénaunay syndrome are hyperintense on T2-weighted images and
lack flow voids. The arteriovenous malformations associated with Parkes Weber
syndrome are high flow because they are fed by the arterial system and
therefore typically have flow voids. Occasionally, however, conventional
angiography or venography is needed to define the vascular lesions associated
with these conditions (Fig.
10B).

View larger version (167K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 11 —22-year-old woman with Kasabach-Merritt syndrome. Axial STIR
MR image (TR/TE, 3,200/55; inversion time, 165 milliseconds; slice thickness,
4 mm) shows presumed hemangiomatosis of spleen and overlying subcutaneous
tissue (arrows). Both splenic and body wall lesions are hyperintense
on STIR images, as is typical of hemangiomas.
|
|

View larger version (125K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12A —25-year-old man with Kasabach-Merritt syndrome. Coronal
T2-weighted single-shot fast spin-echo MR image (TE, 180 milliseconds; slice
thickness, 8 mm) shows innumerable hyperintense lesions within spleen.
|
|

View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12B —25-year-old man with Kasabach-Merritt syndrome.
Contrast-enhanced axial portal venous phase (B) and delayed phase
(C) fat-saturated T1-weighted spoiled gradient-recalled echo MR images
(TR/TE, 4.2/2.0; flip angle, 12°; slice thickness, 4 mm) through upper
part of abdomen show multiple enhanced presumed hemangiomas (hemangiomatosis)
of spleen.
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12C —25-year-old man with Kasabach-Merritt syndrome.
Contrast-enhanced axial portal venous phase (B) and delayed phase
(C) fat-saturated T1-weighted spoiled gradient-recalled echo MR images
(TR/TE, 4.2/2.0; flip angle, 12°; slice thickness, 4 mm) through upper
part of abdomen show multiple enhanced presumed hemangiomas (hemangiomatosis)
of spleen.
|
|
Kasabach-Merritt Syndrome
Kasabach-Merritt syndrome, originally de scribed in 1940, is a rare
condition associated with a vascular lesion; it manifests as consumptive
thrombocytopenia and coagulopathy
[32]. Intralesional
fibrinolysis can cause abnormal laboratory values, including elevation of the
international normalized ratio and D-dimer level (a measure of fibrin split
products). As a consequence, Kasabach-Merritt syndrome can result in severe
disturbances of blood coagulation, such as disseminated intravascular
coagulation.
Kasabach-Merritt syndrome can be found in the setting of a large hepatic or
splenic vascular lesion, most commonly called a hemangioma (Figs.
11,
12A,
12B,
12C,
13A,
13B,
13C,
13D)
[33,
34]. Some authors, however,
have indicated that such lesions are not classic hemangiomas but are tufted
angiomas or kaposiform hemangioendotheliomas
[35]. This syndrome can occur
in infancy as a complication of a large hemangioma or other vascular lesion
usually involving the skin, although deeper lesions may be seen (Fig.
14A,
14B,
14C). In rare instances, a
condition called diffuse neonatal hemangiomatosis occurs that is characterized
by widespread hemangiomas of the skin and viscera. This condition can be
complicated by Kasabach-Merritt syndrome, congestive heart failure, and
gastrointestinal bleeding. Other vascular lesions associated with
Kasabach-Merritt syndrome include angiosarcoma and arteriovenous
malformations.

View larger version (90K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13A —64-year-old man with giant hepatic cavernous hemangioma and
consumptive coagulopathy (elevated international normalized ratio and D-dimer
levels) suggesting Kasabach-Merritt-like syndrome. Abdominal radiograph shows
large upper abdominal mass (arrows) displacing bowel loops into
pelvis.
|
|

View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13B —64-year-old man with giant hepatic cavernous hemangioma and
consumptive coagulopathy (elevated international normalized ratio and D-dimer
levels) suggesting Kasabach-Merritt-like syndrome. Contrast-enhanced coronal
fat-saturated T1-weighted spoiled gradient-recalled echo portal venous phase
MR image (TR/TE, 4.0/2.0; flip angle, 12°, slice thickness, 3 mm)
(B) and 99mTc-labeled RBC nuclear scintigraphic image
(C) confirm presence of extremely large hepatic cavernous hemangioma.
Arrowhead (C) denotes central filling defect consistent with central
scar or thrombus.
|
|

View larger version (156K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13C —64-year-old man with giant hepatic cavernous hemangioma and
consumptive coagulopathy (elevated international normalized ratio and D-dimer
levels) suggesting Kasabach-Merritt-like syndrome. Contrast-enhanced coronal
fat-saturated T1-weighted spoiled gradient-recalled echo portal venous phase
MR image (TR/TE, 4.0/2.0; flip angle, 12°, slice thickness, 3 mm)
(B) and 99mTc-labeled RBC nuclear scintigraphic image
(C) confirm presence of extremely large hepatic cavernous hemangioma.
Arrowhead (C) denotes central filling defect consistent with central
scar or thrombus.
|
|

View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 13D —64-year-old man with giant hepatic cavernous hemangioma and
consumptive coagulopathy (elevated international normalized ratio and D-dimer
levels) suggesting Kasabach-Merritt-like syndrome. Conventional angiogram
after selective celiac artery injection and before transcatheter embolization
of lesion confirms presence of giant cavernous hemangioma.
|
|

View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 14A —2-month-old boy with Kasabach-Merritt syndrome. Axial
contrast-enhanced portal venous phase MR images through levels of midright
kidney (A) and iliac fossae (B) reveal large enhanced
retroperitoneal mass (arrows) extending from left renal hilum to left
midthigh.
|
|

View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 14B —2-month-old boy with Kasabach-Merritt syndrome. Axial
contrast-enhanced portal venous phase MR images through levels of midright
kidney (A) and iliac fossae (B) reveal large enhanced
retroperitoneal mass (arrows) extending from left renal hilum to left
midthigh.
|
|

View larger version (101K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 14C —2-month-old boy with Kasabach-Merritt syndrome. STIR MR image
(TR/TE, 4,000/24; inversion time, 165 milliseconds; section thickness, 5 mm)
shows hyperintense mass (arrows) that represents pathologically
proven hemangioendothelioma.
|
|
Conclusion
The vascular malformation and hemangiomatosis syndromes described represent
a unique group of disease processes with overlapping clinical and radiologic
features. Misdiagnosis is not rare. Although the disorders usually are benign,
diagnosis is critical because these syndromes are associated with a variety of
complications, such as life-threatening hemorrhage. The consistent application
of specific diagnostic criteria leads to reliable diagnosis of these entities.
The diagnostic evaluation of vascular malformations and hemangiomas and
associated syndromes should rely on a combination of clinical expertise and
imaging manifestations.
References
- Vilanova JC, Barcelo J, Smirniotopoulos JG, et al. Hemangioma from
head to toe: MR imaging with pathologic correlation.
RadioGraphics 2004;24
: 367–385[Abstract/Free Full Text]
- Gascoyen M. Case of naevus involving the parotid gland causing
death from suffocation: naevi of the viscera. Trans Pathol Soc
Lond 1860; 11:267
- Bean WB. Blue rubber bleb naevi of the skin and gastrointestinal
tract. In: Thomas CC, ed. Vascular spiders and related lesions of
the skin. Spring-field, IL: Thomas, 1958:178
–185
- Kassarjian A, Fishman SJ, Fox VL, Burrows PE. Imaging
characteristics of blue rubber bleb nevus syndrome.
AJR 2003; 181:1041
–1048[Free Full Text]
- Crosher RF, Blackburn CW, Dinsdale RC. Blue rubber-bleb naevus
syndrome. Br J Oral Maxillofac Surg 1988;26
: 160–164[CrossRef][Medline]
- Dieckmann K, Maurage C, Faure N, et al. Combined laser-steroid
therapy in blue rubber bleb nevus syndrome: case report and review of the
literature. Eur J Pediatr Surg 1994;4
: 372–374[Medline]
- Gallo SH, McClave SA. Blue rubber bleb nevus syndrome:
gastrointestinal involvement and its endoscopic presentation.
Gastrointest Endosc 1992;38
: 72–76[Medline]
- Hofhuis WJ, Oranje AP, Bouquet J, Sinaasappel M. Blue rubber bleb
naevus syndrome: report of a case with consumption coagulopathy complicated by
manifest thrombosis. Eur J Pediatr 1990;149
: 526–528[CrossRef][Medline]
- Yoon W, Jeong YY, Shin SS, et al. Acute massive gastrointestinal
bleeding: detection and localization with arterial phase multi-detector row
helical CT. Radiology 2006;239
: 160–177[Abstract/Free Full Text]
- Cohen MM Jr, Hayden PW. A newly recognized hamartomatous syndrome.
Birth Defects Orig Artic Ser 1979;15
: 291–296[Medline]
- Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg
E. The Proteus syndrome: partial gigantism of the hands and/or feet, nevi,
hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies
and possible accelerated growth and visceral affections. Eur J
Pediatr 1983; 140:5
–12[CrossRef][Medline]
- Happle R. Lethal genes surviving by mosaicism: a possible
explanation for sporadic birth defects involving the skin. J Am
Acad Dermatol 1987; 16:899
–906[Medline]
- Samlaska CP, Levin SW, James WD, Benson PM, Walker JC, Perlik PC.
Proteus syndrome. Arch Dermatol 1989;125
:1109
–1114[Abstract/Free Full Text]
- Jamis-Dow CA, Turner J, Biesecker LG, Choyke PL. Radiologic
manifestations of Proteus syndrome. RadioGraphics2004; 24:1051
–1068[Abstract/Free Full Text]
- Biesecker LG, Happle R, Mulliken JB, et al. Proteus syndrome:
diagnostic criteria, differential diagnosis, and patient evaluation.
Am J Med Genet 1999;84
: 389–395[CrossRef][Medline]
- Cremin BJ, Viljoen DL, Wynchank S, Beighton P. The Proteus
syndrome: the magnetic resonance and radiological features. Pediatr
Radiol 1987; 17:486
–488[CrossRef][Medline]
- Azouz EM, Costa T, Fitch N. Radiologic findings in the Proteus
syndrome. Pediatr Radiol 1987;17
: 481–485[CrossRef][Medline]
- DeLone DR, Brown WD, Gentry LR. Proteus syndrome: craniofacial and
cerebral MRI. Neuroradiology 1999;41
: 840–843[CrossRef][Medline]
- Newman B, Urbach AH, Orenstein D, Dickman PS. Proteus syndrome:
emphasis on the pulmonary manifestations. Pediatr
Radiol 1994; 24:189
–193[CrossRef][Medline]
- Klippel M, Trénaunay P. Du naevus variqueux
osteohypertrophique. Arch Genet Med Paris1900; 3:611
–672
- Weber FP. Angioma formation in connection with hypertrophy of limbs
and hemihypertrophy. Br J Dermatol 1907;19
: 231–235
- Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP,
Gloviczki P. Klippel-Trénaunay syndrome: spectrum and management.
Mayo Clin Proc 1998;73
: 28–36[Abstract]
- Cha SH, Romeo MA, Neutze JA. Visceral manifestations of
Klippel-Trenaunay syndrome. RadioGraphics2005; 25:1694
–1697[Free Full Text]
- Kinmonth JB, Young AE, Edwards JM, O'Donnell TF, Thomas ML. Mixed
vascular deformities of the lower limbs, with particular reference to
lymphography and surgical treatment. Br J Surg1976; 63:899
–906[Medline]
- Berry SA, Peterson C, Mize W, et al. Klippel-Trénaunay
syndrome. Am J Med Genet 1998;79
: 319–326[CrossRef][Medline]
- Baskerville PA, Ackroyd JS, Lea Thomas M, Browse NL. The
Klippel-Trénaunay syndrome: clinical, radiological, and haemodynamic
features and management. Br J Surg 1985;72
: 232–236[Medline]
- Servelle M, Bastin R, Loygue J, et al. Hematuria and rectal
bleeding in the child with Klippel and Trénaunay syndrome.
Ann Surg 1976;183
: 418–428[Medline]
- Wilson CL, Song LM, Chua H, et al. Bleeding from cavernous
angiomatosis of the rectum in Klippel-Trénaunay syndrome: report of
three cases and literature review. Am J Gastroenterol2001; 96:2783
–2788[Medline]
- Schmitt B, Posselt HG, Waag KL, Muller H, Bender SW. Severe
hemorrhage from intestinal hemangiomatosis in Klippel-Trénaunay
syndrome: pitfalls in diagnosis and management. J Pediatr
Gastroenterol Nutr 1986; 5:155
–158[Medline]
- Furness PD 3rd, Barqawi AZ, Bisignani G, Decter RM.
Klippel-Trénaunay syndrome: 2 case reports and a review of
genitourinary manifestations. J Urol2001; 166:1418
–1420[CrossRef][Medline]
- Kuo PH, Chang YC, Liou JH, Lee JM. Mediastinal cavernous
haemangioma in a patient with Klippel-Trénaunay syndrome.
Thorax 2003; 58:183
–184[Abstract/Free Full Text]
- Al-Mazrou KA, Richardson MA. Kasabach-Merritt phenomenon.
Saudi Med J 2005;26
:1286
–1288[Medline]
- Dufau JP, le Tourneau A, Audouin J, Delmer A, Diebold J. Isolated
diffuse hemangiomatosis of the spleen with Kasabach-Merritt–like
syndrome. Histopathology 1999;35
: 337–344[CrossRef][Medline]
- Linderkamp O, Hopner F, Klose H, Riegel K, Hecker WC. Solitary
hepatic hemangioma in a newborn infant complicated by cardiac failure,
consumption coagulopathy, microangiopathic hemo lytic anemia, and obstructive
jaundice: case report and review of the literature. Eur J
Pediatr 1976; 124:23
–29[CrossRef][Medline]
- Enjolras O, Wassef M, Mazoyer E, et al. Infants with
Kasabach-Merritt syndrome do not have "true" hemangiomas.
J Pediatr 1997;130
: 631–640[CrossRef][Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. I. Alomari
Vascular Anomalies: Nosologic and Diagnostic Dilemma
Am. J. Roentgenol.,
October 1, 2008;
191(4):
W192 - W192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Elsayes, J. R. Dillman, C. O. Menias, J. F. Platt, and J. P. Heiken
Reply
Am. J. Roentgenol.,
October 1, 2008;
191(4):
W193 - W194.
[Full Text]
[PDF]
|
 |
|